title: Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease.
abstract: Isotretinoin is a widely prescribed medication for nodulocystic acne. Existing literature is conflicting regarding an association between isotretinoin and inflammatory bowel disease. In this issue, Alhusayen et al. report findings from a 12-year observational study exploring a possible association, and they conclude that acne itself may be responsible for an apparent correlation.
authors.affiliation: Department of Dermatology, Harvard Medical School, Boston, MA, USA.
authors.forename: Alisa N
authors.initials: AN
authors.lastname: Femia
authors.forename: Ruth
authors.initials: R
authors.lastname: Ann Vleugels
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology*; D015474:Isotretinoin / Q000009:adverse effects*; D008297:Male
chemical_list: D015474:Isotretinoin